Following our first successful meeting earlier this year, the ADRC ‘Ageing and Dementia Friendly Design Advisory Board’ met for the second time in June 2017. The Advisory Board brings together internal staff and external members such as architects, designers and care home managers and developers (see previous article for a full list of membership*). The purpose of the Advisory Board is to exchange knowledge between academics and external stakeholder, to discuss findings from our research into the effects of typical and atypical ageing on wayfinding and navigation and – importantly – to translate research findings into practice-relevant design guidelines for the built environment that minimises spatial disorientation in later life.
In this meeting Prof Jan Wiener provided Advisory Board members with an overview of the relevant research findings and suggested new, improved design guidelines focusing on the use of landmarks to support orientation. The group discussed these findings and provided feedback about how these guidelines might be implemented, published and disseminated in the future. ADRC will continue discussions with the Advisory Board when they meet next in September 2017.
For more information about this research or the ADRC please contact Prof Jan Wiener jwiener@bournemouth.ac.uk











BU Annual Research Conference: Poster Exhibition Call for Applications
Vitae Three Minute Thesis (3MT®) Competition: Applications Now Open
3C Online Social: Thursday 26 March 1–2pm – Research Culture, Community & Can you Guess Who?
Four BU students at national midwifery conference
INRC book roundtable/presentation by Drs Jonathan Cole and Catherine Talbot, Wednesday 22/04/2026, 13:00h, P426
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease